Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
The U.S. Environmental Protection Agency (EPA) announced today that the first rule to be finalized under the Toxic Substance Control Act is a ban on
Data from a positive phase 2/3 clinical trial evaluating the effectiveness of a drug for mesothelioma was just published in the Journal of the American
Melina Marmarelis, MD, Thoracic Medical Oncologist, UPenn joins us for an interview about precision medicine for mesothelioma. She discusses biomarker information, such as histology (currently
Hair loss, or alopecia, is often associated with cancer therapies and, in particular, with cytotoxic chemotherapy. While this side effect is most often temporary –
Due to recent advances in cancer treatment, especially in the field of immunotherapy, chemotherapy treatment options for mesothelioma have taken a back seat. However, this
This article aims to build on the Part 1 of this series. Out of necessity, mesothelioma patients more than other patient groups are savvy consumers
UPDATE: Deadline extended to November 17 at 11:59 PM ET. Thanks to the generous support of our patients, families, caregivers, corporate supporters, and the many
A group of patients joins the patient panel at the 2023 International Symposium on Malignant Mesothelioma to discuss their experiences of diagnosis, finding an expert